|
Volumn 42, Issue 5, 2008, Pages 233-240
|
Osteotropic radiopharmaceuticals based on phosphonic acids for the treatment of bone metastases in humans (review)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 SULFONOETHYLIDENE 1,1 DIPHOSPHONIC ACID;
BENZYLMETHYLENEDIPHOSPHONIC ACID TC 99M;
BISPHOSPHONIC ACID DERIVATIVE;
BUTYLENEDIAMINETETRAMETHYLENEPHOSPHONIC ACID;
DIMETHYLPROPYLENEDIAMINETETRAMETHYLENEPHOSPHONIC ACID;
ETHYLENEDIAMINE TETRAMETHYLENEPHOSPHONATE RHENIUM 188;
ETHYLENEDIPHOSPHONIC ACID TC 99M;
ETIDRONIC ACID;
ETIDRONIC ACID RE 186;
ETIDRONIC ACID RE 188;
ISOPROPYLIDENEDIPHOSPHONIC ACID TC 99M;
LEXIDRONAM SAMARIUM SM 153;
MEDRONATE RHENIUM RE 188;
MEDRONATE TECHNETIUM TC 99M;
MEDRONIC ACID;
NITRILOTRIMETHYLENEPHOSPHONIC ACID;
OXIDRONIC ACID;
PENTETIC ACID TIN 117M;
PHOSPHONIC ACID DERIVATIVE;
PHOSPHORUS 32;
RADIOISOTOPE;
RADIOPHARMACEUTICAL AGENT;
RHENIUM 186;
RHENIUM 188;
SAMARIUM 153;
STRONTIUM 89;
TECHNETIUM 99M;
TIN 117M;
TUNGSTEN 188;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
BETA RADIATION;
BONE METASTASIS;
DRUG ACCUMULATION;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
NONHUMAN;
RADIATION EXPOSURE;
REVIEW;
STRUCTURE ANALYSIS;
|
EID: 55949121571
PISSN: 0091150X
EISSN: 15739031
Source Type: Journal
DOI: 10.1007/s11094-008-0109-7 Document Type: Review |
Times cited : (9)
|
References (96)
|